Blackrock Technology And Stock Today
| BTX Stock | USD 7.44 0.12 1.64% |
PerformanceOK
| Odds Of DistressLow
|
BlackRock Technology is trading at 7.44 as of the 27th of June 2025; that is 1.64 percent up since the beginning of the trading day. The stock's open price was 7.32. BlackRock Technology has less than a 11 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. BlackRock Technology symbol was changed from BIGZ on 20th of February 2025. The performance scores are derived for the period starting the 29th of March 2025 and ending today, the 27th of June 2025. Click here to learn more.
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Brooklyn ImmunoTherapeutics, Inc. is based in Brooklyn, New York. Brooklyn ImmunoTherapeuti operates under Biotechnology classification in the United States and is traded on ASE Exchange. The company has 213.34 M outstanding shares of which 1 M shares are currently shorted by investors with about 0.54 days to cover. More on BlackRock Technology and
Moving together with BlackRock Stock
Moving against BlackRock Stock
BlackRock Stock Highlights
| Older Symbol | BIGZ |
| CEO Director | Matthew Angel |
| Old Name | Forbuild SA |
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Financial Services, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
BlackRock Technology and (BTX) is traded on New York Stock Exchange in USA. It is located in 50 Hudson Yards, New York, NY, United States, 10001 and employs 7 people. BlackRock Technology and was previously known as Blackrock Innovation Growth and was traded on New York Stock Exchange under the symbol BIGZ. BlackRock Technology is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a total capitalization of 1.56 B. BlackRock Technology and runs under Biotechnology sector within Health Care industry. The entity has 213.34 M outstanding shares of which 1 M shares are currently shorted by investors with about 0.54 days to cover.
BlackRock Technology and has about 19.41 M in cash with 277.21 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.33.
Check BlackRock Technology Probability Of Bankruptcy
Ownership AllocationBlackRock Technology holds a total of 213.34 Million outstanding shares. 30% of BlackRock Technology and outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check BlackRock Ownership Details
BlackRock Technology and Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. BlackRock Technology market risk premium is the additional return an investor will receive from holding BlackRock Technology long position in a well-diversified portfolio.
| Risk Adjusted Performance | 0.2112 | |||
| Jensen Alpha | 0.2644 | |||
| Total Risk Alpha | 0.2554 | |||
| Sortino Ratio | 0.106 |
BlackRock Stock Against Markets
BlackRock Technology Corporate Management
| Susan McClatchey | VP Quality | Profile | |
| Andrew Jackson | Chief Officer | Profile | |
| Sandra Gurrola | Principal Fin | Profile | |
| Roger MD | Chief Officer | Profile | |
| PharmD MBA | Chief Officer | Profile | |
| Lynn MS | Ex Operations | Profile |
Additional Tools for BlackRock Stock Analysis
When running BlackRock Technology's price analysis, check to measure BlackRock Technology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BlackRock Technology is operating at the current time. Most of BlackRock Technology's value examination focuses on studying past and present price action to predict the probability of BlackRock Technology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BlackRock Technology's price. Additionally, you may evaluate how the addition of BlackRock Technology to your portfolios can decrease your overall portfolio volatility.